← Leaderboards
Virgil Brown
Emory University
$49,528
Attributed
$49,528
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $24.8K · FY2005–07$25K$18.8K$12.5K$6.3K$0
'05
'06
'07
Funding mix
By agency
NIH$49,528 · 5
By mechanism
M01$49,528 · 5
Top collaborators
No co-investigators on record.
Most similar at Emory University
Same institution · by research overlap
- Sampath Parthasarathy$11,379,014
- Miriam B. Vos$5,544,207
- Shakira Franco Suglia$12,162,605
- Ana Alvarez Murphy$1,141,601
- Virgil W Brown$1,942,901
Others in their field
Top investigators on “Hyperlipidemia”
- Curtis L Meinert · Johns Hopkins University$22,890,517
- Jeff Douglas Williamson · Wake Forest University Health Sciences$20,997,388
- Walter T Ambrosius · Indiana Univ-Purdue Univ At Indianapolis$20,997,388
- Adrian Hernandez · Duke University$20,997,388
- Karen P Alexander · Duke University$20,997,388
- James F Meschia · Mayo Clinic Coll Of Med, Jacksonville$19,557,831
Research focus
HyperlipidemiaHypertriglyceridemiaFamilial HyperlipoproteinemiaApolipoproteinsLipoprotein LipaseGene MutationBlood Lipoprotein BiosynthesisClinical ResearchHuman SubjectApolipoprotein BLow-Density LipoproteinsMetabolismPlacebosPlasmaProteinsResearch PersonnelResourcesRosuvastatinSequential TreatmentSourceStable Isotope LabelingUnited States National Institutes Of HealthVery Low Density LipoproteinComputer Retrieval Of Information On Scientific Projects Database
Grant awards (7)
EFFECT OF CRESTOR ON LIPOPROTEIN METABOLISM IN HUMANS$24,848
M01 · FY2007 · RR · contact PI
LIPOPROTEIN METABOLISM$15,619
M01 · FY2006 · RR · contact PI
PROTEASE INHIBITOR-INDUCED HYPERLIPIDEMIA IN AIDS$6,645
M01 · FY2005 · RR
PROTEASE INHIBITOR-INDUCED HYPERLIPIDEMIA IN AIDS$2,416
M01 · FY2005 · RR
OVERPRODUCTION OF APOC III IN HYPERTRIGLYCERIDEMIA$0
M01 · FY2002 · RR
OVERPRODUCTION OF APOC III IN HYPERTRIGLYCERIDEMIA$0
M01 · FY2002 · RR
OVERPRODUCTION OF APOC III IN HYPERTRIGLYCERIDEMIA$0
M01 · FY2001 · RR